WCG has launched the WCG Study Accelerator, an integrated solution designed to optimise the clinical trial process and ...

CROs remain delivery partners, but sponsors align content and expectations across studies This hybrid approach boosts site readiness, reduces protocol deviations, and creates a scalable learning ...

At CTO West Coast an expert from Genentech outlined the company’s net zero goals, efforts, challenges and initiatives ...

To “economically” weave the patient experience into the fabric of clinical trials, sponsors should consider ... wanting to go to a traditional study site. Some may be willing to attend on ...

Although comprehensive genomic profiling (CGP) expands access to clinical trials ... sponsors and sites must both see advantages. A key decision is whether to adopt a site-owned or sponsor ...

Participation in clinical trials improves health outcomes, yet regional, rural, and socially disadvantaged populations face disparity in access to clinical trials. Decentralised clinical trial (DCT) ...

Clinical trials are essential for advancing medical treatments, yet participation from Black communities remains low due to misinformation.

The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials ...

Audit preparedness is essential for every clinical research site. By operationalizing compliance in your daily procedures, you can ...

we have been able to research the evidence that will help women with big babies to make informed choices." Katie Morris, NIHR National Clinical Specialty Lead for Reproductive Health and ...